SHE logo

Shedir Pharma Group S.p.A. Stock Price

BIT:SHE Community·€55.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

SHE Share Price Performance

€0
0.00 (0.00%)
€0
0.00 (0.00%)
Price €0

SHE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and undervalued.

2 Risks
3 Rewards

Shedir Pharma Group S.p.A. Key Details

€61.0m

Revenue

€42.1m

Cost of Revenue

€18.9m

Gross Profit

€12.9m

Other Expenses

€6.0m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
0.53
31.02%
9.84%
7.3%
View Full Analysis

About SHE

Founded
2008
Employees
84
CEO
Antonio Scala
WebsiteView website
www.shedirpharma.com

Shedir Pharma Group S.p.A., through its subsidiaries, engages in the research, formulation, development, and marketing of nutraceuticals, dermocosmetics, medical devices, and pharmaceutical products in Italy. It provides products for andrological, cardiovascular, dermatological, hematological, energy, gastrointestinal, gynecological, metabolic, neurological, dental, ophthalmic, osteoarticular, otologic, respiratory, and trichological diseases. The company offers its products through a network of sales agents, wholesalers, and pharmacies. Shedir Pharma Group S.p.A. was founded in 2008 and is based in Naples, Italy. Shedir Pharma Group S.p.A. operates as a subsidiary of Dimainvest S.r.l.

Recent SHE News & Updates

Shedir Pharma Group S.p.A.'s (BIT:SHE) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Nov 08
Shedir Pharma Group S.p.A.'s (BIT:SHE) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Recent updates

No updates